Infertility can be defined as the inability of an individual to reproduce by natural means. The causes of infertility are extremely diverse. It can be due to advancement of maternal age, disorders in the occurrence of ovulation, tubal occlusion or blockage, genetics, sexually transmitted infections, immune infertility, endometrial polyps, uterine fibroids, infertility due to male factors, endometriosis, and others. According to CDC, in the U.S., 1 in every 8 couples or approximately 12% of married women face complications to attain pregnancy. Around one third infertility cases are due to the female partner, another one third due to the male counterpart, and the remaining are attributed to both the partners or other unexplained infertility causes. Fertility rate has halved since 1960. Treatment options for infertility include education or spreading awareness, medications to assist the development of egg during the ovulation period, insemination, in vitro fertilization (IVF), and third party reproduction surgery.
Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54786
Increase in the number of cases of infertility can be attributed to rise in physical inactivity, continual shift toward sedentary lifestyle, improper fetal care, delayed pregnancy, smoking, excessive consumption of alcohol, stress, and others. Moreover, rise in prevalence of diabetes and obesity is the key factor contributing to the increase in rate of these conditions. Surge in the number of fertility clinics across the world coupled with advancement in technologies to treat infertility among both men and women drives the global infertility treatment market. Furthermore, increase in investments by the public and private sectors in the health care industry has led to a conducive environment for the growth of the global infertility treatment market. However, high cost of procedures associated with reproductive techniques and other factors such as decreased efficacy among elderly women are likely to be major restraints of the global infertility treatment market in the next few years.
Request for Analysis of COVID19 Impact on Infertility Treatment Market –
The global infertility treatment market can be segmented based on product, procedure, patient type, end-user, and region. In terms of product, the infertility treatment market can be classified into equipment, media & consumables, and accessories. The equipment segment can be categorized into microscopes, sperm analyzer systems, imaging systems, micromanipulators systems, ovum aspiration pumps, cryosystems, incubators, gas analyzers, and laser systems. Based on procedure, the global infertility treatment market can be divided into assisted reproductive technology, artificial insemination, fertility surgery, and others. The assisted reproductive technology segment can be classified into in vitro fertilization, surrogacy, and intra-cytoplasmic sperm injection (ICSI). The artificial insemination segment can be categorized into intrauterine insemination, intracervical insemination, and intratubal insemination. The fertility surgery segment can be divided into myomectomy, laparoscopy, hysteroscopy, varicocelectomy, laparotomy, tubal ligation reversal, and microsurgical reconstruction. In terms of patient type, the infertility treatment market can bifurcated into male and female. Based on end-user, the global infertility treatment market can be classified into hospitals & surgical clinics, fertility centers, research institutes, and cryobanks.
Pre book Market Report –
In terms of region, the global infertility treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major share of the global infertility treatment market in terms of revenue in 2017. High growth of the infertility treatment market in the region can be attributed to increase in investments in R&D, high awareness, favorable rules & regulations and reimbursement policies by governmental bodies, increase in health care expenditure, and others. Europe accounted for significant share of the global infertility treatment market in terms of revenue in 2017. However, the market in Asia Pacific is expected to expand at a high CAGR during the forecast period. Increase in awareness and population, and rise in support in terms of investments by the public and private sectors are likely to drive the market in the region in the near future. The market in Middle East & Africa and Latin America is projected to witness moderate growth during the forecast period. Growth in these region can be attributed to evolving lifestyle, increased adoption of smoking, consumption of alcohol and increase in sedentary lifestyle.
Ask for Discount:
Key players operating in the global infertility treatment market include Cook Group Incorporated, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne, Ltd., Ihmedical A/S, Irvine Scientific (A Member of Jx Holdings Group), IVFTech Aps, Kitazato Corporation, Medgyn Products, Inc., and Rocket Medical plc.
Browse More Trending Reports by Transparency Market Research:
Antimicrobial Susceptibility Test Market :
Alpha Mannosidosis Market :
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453